Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.25%
SPX
+0.21%
IXIC
+0.45%
FTSE
+0.14%
N225
0.00%
AXJO
0.00%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
1.89M
Dividend Yield
0.00%
P/E Ratio
-0.11
EPS
-45.36
Revenue
-
Avg. Volume
48.86K

About

What does INDP do?
Indaptus Therapeutics, a preclinical biotechnology company based in New York City, focuses on multi-targeted immune system activation using a Decoy platform for anti-tumor and anti-viral responses. Its lead candidate, Decoy20, shows promise against chronic HBV and HIV infections.
Sector
💻 Health Care
IPO
CEO
Employees
7
Headquarters
Israel
Website
http://www.intecpharma.com

Recently from Cashu

publisher logo
Cashu

Indaptus Therapeutics: Innovating Cancer Treatment in the Immuno-Oncology Sector

4 days ago
publisher logo
Cashu

Indaptus Therapeutics: Pioneering Innovative Cancer Treatments in a Competitive Biotechnology Landscape

6 days ago
publisher logo
Cashu

Indaptus Therapeutics: Overview and Key Developments in Recent Performance

17 days ago
Stocks
Health Care
indp
Indaptus Therapeutics
NASDAQ: INDP
-0.38 (-11.60%)
2.92
USD
At close at Sep 08, 20:39 UTC
Summary
News
Signals
Benchmarks
Financials